MUDr. Marek Slávik, Ph.D.
Department vice-head for research and development, Department of Radiation Oncology
Total number of publications: 40
2021
-
Preoperative Chemoradiotherapy for Gastroesophageal Junction Adenocarcinoma Modified by PET/CT: Results of Virtual Planning Study
Medicina-Lithuania, year: 2021, volume: 57, edition: 12, DOI
-
Stereotactic Body Radiotherapy for Lymph Node Oligometastases: Real-World Evidence From 90 Consecutive Patients
Frontiers in Oncology, year: 2021, volume: 10, edition: FEB 2021, DOI
2020
-
Acupuncture in the treatment of acute toxicity during and after head and neck cancer radiotherapy: Interim analysis of randomized prospective open-label trial
Biomedical Papers, year: 2020, volume: 164, edition: 4, DOI
-
Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic
Cancers, year: 2020, volume: 12, edition: 12, DOI
-
Salivary microRNAs identified by small RNA sequencing as potential predictors of response to intensity-modulated radiotherapy in head and neck cancer patients
CELLULAR ONCOLOGY, year: 2020, volume: 43, edition: 3, DOI
-
The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma
JOURNAL OF ORAL PATHOLOGY & MEDICINE, year: 2020, volume: 49, edition: 9, DOI
-
The tumour immune microenvironment and its implicationsfor clinical outcome in patients with oropharyngeal squamouscell carcinoma
Year: 2020, type: Conference abstract
2019
-
Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study
Neoplasma, year: 2019, volume: 66, edition: 2, DOI
-
Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy
Head and Neck, year: 2019, volume: 41, edition: 4, DOI
-
MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy
CANCER GENOMICS & PROTEOMICS, year: 2019, volume: 16, edition: 2, DOI